Neurology

In a study with 147 participants, SAGE-324 did not show a statistically significant dose-response relationship…

Investigators found that in melanomas in particular, interleukin-6 blockade seems to be effective in the…

Pending positive results from an early-stage trial, a mid-stage study evaluating MyoPAXon’s effect on other…

Treated patients demonstrated improvements on the Bayley-4 in cognition, communication, and motor function that exceeded…

The president and CEO at Alzheon shared recent insights into neurodegenerative diseases that suggest a…

The director of movement disorders at the Banner Sun Health Research Institute talked about recent,…

Steve Hoffman, MS, and Alessio Travaglia, PhD, provide commentary on a recently launched public-private partnership…

Antonella Favit-Van Pelt, MD, PhD, chief medical officer at Helius Medical Technologies, gave perspective on…

The professor of neurology at Stony Brook Medicine talked about the promising potential in ongoing…

In the event that a patient inadvertently took a 0.25 mg dose rather than the…